OXT and cardiomyopathy: Similar with above‐mentioned studies, Plante et al. found that oxytocin treatment could prevented the cardiomyopathy in obese diabetic male db/db mice via partially improving fat and glucose metabolism and preventing systolic and diastolic dysfunction, cardiomyocyte hypertrophy, fibrosis as well as apoptosis.37